Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−14.96 USD
−18.56 M USD
0.00 USD
1.59 M
About QUANTUM BIOPHARMA LTD. CLASS B SUBORDINATE VOTING SHARES
Sector
Industry
CEO
Zeeshan Saeed
Website
Headquarters
Toronto
Founded
1994
FIGI
BBG00L45SFK1
Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of QNTM is 3.49 USD — it has increased by 3.43% in the past 24 hours. Watch Quantum Biopharma Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Quantum Biopharma Ltd. stocks are traded under the ticker QNTM.
QNTM stock has fallen by −20.19% compared to the previous week, the month change is a −38.86% fall, over the last year Quantum Biopharma Ltd. has showed a −71.61% decrease.
We've gathered analysts' opinions on Quantum Biopharma Ltd. future price: according to them, QNTM price has a max estimate of 12.79 USD and a min estimate of 12.79 USD. Watch QNTM chart and read a more detailed Quantum Biopharma Ltd. stock forecast: see what analysts think of Quantum Biopharma Ltd. and suggest that you do with its stocks.
QNTM reached its all-time high on Aug 9, 2024 with the price of 23.81 USD, and its all-time low was 2.70 USD and was reached on Dec 20, 2024. View more price dynamics on QNTM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
QNTM stock is 9.37% volatile and has beta coefficient of 3.39. Track Quantum Biopharma Ltd. stock price on the chart and check out the list of the most volatile stocks — is Quantum Biopharma Ltd. there?
Today Quantum Biopharma Ltd. has the market capitalization of 6.33 M, it has decreased by −5.54% over the last week.
Yes, you can track Quantum Biopharma Ltd. financials in yearly and quarterly reports right on TradingView.
Quantum Biopharma Ltd. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
QNTM earnings for the last quarter are −2.88 USD per share, whereas the estimation was −2.77 USD resulting in a −3.90% surprise. The estimated earnings for the next quarter are −0.78 USD per share. See more details about Quantum Biopharma Ltd. earnings.
Quantum Biopharma Ltd. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach 925.91 K USD.
QNTM net income for the last quarter is −3.86 M USD, while the quarter before that showed −3.11 M USD of net income which accounts for −24.00% change. Track more Quantum Biopharma Ltd. financial stats to get the full picture.
No, QNTM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, QNTM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Quantum Biopharma Ltd. stock right from TradingView charts — choose your broker and connect to your account.